Avanos Medical (AVNS) Capital Expenditures (2013 - 2026)

Avanos Medical has disclosed Capital Expenditures across 14 years of filings, most recently posting $4.3 million for Q1 2026.

• Capital Expenditures for Q1 2026 came in at $4.3 million, down 35.82% year-over-year; the trailing twelve-month figure through Mar 2026 was -$800000.0 (down 109.76% YoY), and the FY2025 annual result was $1.6 million, down 71.43% from the prior year.
• Capital Expenditures came in at $4.3 million for Q1 2026 at Avanos Medical, up from -$23.1 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $11.0 million in Q2 2025 to a low of -$23.1 million in Q4 2025.
• The 5-year median for Capital Expenditures is $4.1 million (2022), against an average of $2.0 million.
• Across the five-year window, Capital Expenditures soared 156.19% in 2023 and slumped 225.42% in 2024, its largest moves.
• Avanos Medical's Capital Expenditures stood at -$10.5 million in 2022, then jumped by 156.19% to $5.9 million in 2023, then plunged by 225.42% to -$7.4 million in 2024, then tumbled by 212.16% to -$23.1 million in 2025, then surged by 118.61% to $4.3 million in 2026.
• The last three Capital Expenditures figures came in at $4.3 million (Q1 2026), -$23.1 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.